DNA-HIVE also known as just HIVE or FDA-HIVE is a fast-growing start-up supporting healthcare ecosystem stakeholders in key areas of biomedical research and information technologies. In this era of precision therapeutics, molecular diagnostics, personalized devices and interventions no clinical study can succeed without technological solutions supporting large scale data generation, archival and analysis. Development and evaluation of medical products involves multiple stakeholders in complex interrelations between tech companies, pharma, med-tech industry, CROs and regulators.
Our company provides technological solutions as well as expertise that target pre-clinical, clinical and real-world evidence that integrate classical robust approaches with novel methodologies that employ innovative registries, mobile facing applications and multi-omics. Our technology supports critical operating protocols within the federal government, academia and industry. We have advanced research, regulatory and clinical expertise to support medical product manufacturing and evaluation lifecycle.
Leadership & Advisory Board
Vahan Simonyan
Dr Simonyan is the Chief Scientist of DNA-HIVE and Adjunct Professor of Biostatistics and Bioinformatics at the George Washington University. He served as a Lead IT Architect at NIH and FDA
Art Sedrakyan
Art Sedrakyan, M.D., Ph.D. Medical and Research Advisor, is a clinical and health services researcher with over 20 years of experience. He is a tenured professor at Weill Cornell Medicine
Adam Beck
Adam Beck, M.D., F.A.C.S. Advisor, is the Chair of the Division vascular surgery and Director of Vascular Surgery and Endovascular Therapy at the University of Alabama at Birmingham (UAB)
Philip Goodney
Philip P. Goodney, M.D., M.S. Advisor, is the Vice Chair of Research in the Department of Surgery and Director of the Center for the Evaluation of Surgical Care at Dartmouth (CESC)
Bilal Chughtai
Bilal Chughtai, M.D. Advisor, is a urologist, health researcher and Associate Professor of Urology and Obstetrics and Gynecology at Weill Cornell Medicine/New York-Presbyterian Hospital
Jeffrey Milsom
Jeffrey Milsom, M.D. Advisor, is a leading colon and rectal surgeon with over 35 years of experience, innovator, and professor of Surgery New York Presbyterian -Weill Cornell Medical Center since 2001
Christian Behrednt
Christian-Alexander Behrendt, M.D. Advisor, is a vascular surgeon in Germany, outcomes researcher and is head of the research group at GermanVasc at the University Medical Center Hamburg-Eppendorf (UKE)
Bradley B. Pua
Bradley B. Pua, M.D. Advisor is the Chief of Division of Interventional Radiology, and Director, Radiology Consultation Services at Weill Cornell Medicine/New York Presbyterian Hospital
Frederic Resnic
Frederic S. Resnic, M.D. Advisor, is an interventional cardiologist who serves as the Chairman of the Department of Cardiovascular Medicine at the Lahey Hospital and Medical Center/Tufts University
Raja Mazumder
Dr. Mazumder is advisor and serves as a Professor of Biochemistry and Molecular Medicine and Co-Director of The McCormick Genomic Proteomic Center at The George Washington University (GW)
Rick Kuntz
Dr. Rick Kuntz is Senior Vice President, Chief Medical and Scientific Officer of Medtronic. He oversees the company’s medical affairs, health policy and reimbursement, clinical research activities, and corporate technology
David Liebeskind
Dr. David Liebskind is the director of the UCLA Stroke Center, Professor of Neurology, UCLA Department of Neurology, and the director of Neurovascular Imaging Research Core